Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.33 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.33 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | GJB2 | P29033 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15304344 | 1.00 | MAPK1 (0.34) | MAPK1LGALS8LGALS3LGALS4L3MBTL1 | |
| SCHEMBL14536556 | 1.00 | MAPK1 (0.34) | MAPK1LGALS8LGALS3LGALS4L3MBTL1 | |
| SCHEMBL25597683 | 0.86 | GJB2 (0.38) | MAPK1LGALS8LGALS3LGALS4GJB2 | |
| SCHEMBL15935858 | 0.85 | LGALS8 (0.41) | MAPK1LGALS8LGALS3L3MBTL1CA1 | |
| SCHEMBL13073700 | 0.81 | LGALS8 (0.44) | MAPK1LGALS8LGALS3LGALS4L3MBTL1 | |
| SCHEMBL10820762 | 0.81 | SLC2A1 (0.37) | LGALS8LGALS3LGALS4GAA | |
| SCHEMBL26262226 | 0.81 | LGALS3 (0.40) | MAPK1LGALS8LGALS3LGALS4L3MBTL1 | |
| SCHEMBL9968286 | 0.81 | LGALS8 (0.31) | MAPK1LGALS8LGALS3LGALS4L3MBTL1 | |
| SCHEMBL14511583 | 0.81 | L3MBTL1 (0.36) | LGALS8LGALS3LGALS4L3MBTL1MAPT | |
| SCHEMBL13241371 | 0.81 | LGALS8 (0.31) | MAPK1LGALS8LGALS3LGALS4L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2567964-A2 | Monomer Compositions for the Synthesis of RNA, Methods of Synthesis, and Methods of Deprotection | Agilent Technologies, Inc. (US) | 2013-03-13 | — | — | EP | disclosed |
| US-8202985-B2 | Monomer compositions for the synthesis of polynucleotides, methods of synthesis, and methods of deprotection | AGILENT TECHNOLOGIES, INC. (US) | 2012-06-19 | — | — | US | disclosed |
| US-7759471-B2 | nucleotide monomer used to make protected RNA that has similar stability to the DNA molecule | AGILENT TECHNOLOGIES, INC. (US) | 2010-07-20 | — | — | US | disclosed |